Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000905148-17-000702)

Filing Details

Accession Number:: 0000905148-17-000702
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-07-28 16:29:23
Reporting Period:: 2017-06-19

Filing Date:: 2017-07-28
Accepted Time:: 2017-07-28 16:29:23
Original Submission Date:: 2017-06-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1300699	Athenex Inc.	ATNX	Pharmaceutical Preparations (2834)	431985966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1708965	Rudolf Kwan	C/O Athenex, Inc., 1001 Main Street Suite 600 Buffalo NY 14203	Evp, Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-19	49,700	$11.00	49,700	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares of Common Stock ("Shares") were inadvertently omitted from the Reporting Person's Form 4 filed June 21, 2017.
These Shares were purchased in the Issuer's initial public offering, which closed on June 19, 2017.